Compile Data Set for Download or QSAR
maximum 50k data

Found 24 hits with Target = 'leucine--trna ligase'   

CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630176(US11802110, Compound R-4.1)
ITC DataΔG°: -48.1kJ/mole −TΔS°: 0kJ/mole ΔH°: -49.9kJ/mole logk: 2.02E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630410(US11802110, Compound 4.39)
ITC DataΔG°: -45.1kJ/mole −TΔS°: -7.96kJ/mole ΔH°: -38.9kJ/mole logk: 8.23E+5
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630389(US11802110, Compound 4.4)
ITC DataΔG°: -38.9kJ/mole −TΔS°: 0kJ/mole ΔH°: -37.9kJ/mole logk: 1.27E+5
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630390(US11802110, Compound 4.7)
ITC DataΔG°: -32.8kJ/mole −TΔS°: -23.9kJ/mole ΔH°: -6.95kJ/mole logk: 2.01E+4
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630391(US11802110, Compound 4.11)
ITC DataΔG°: -49.5kJ/mole −TΔS°: 19.9kJ/mole ΔH°: -67.9kJ/mole logk: 3.11E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630392(US11802110, Compound R-4.12)
ITC DataΔG°: -50.1kJ/mole −TΔS°: -3.98kJ/mole ΔH°: -45.0kJ/mole logk: 3.71E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630393(US11802110, Compound 4.13)
ITC DataΔG°: -46.7kJ/mole −TΔS°: -11.9kJ/mole ΔH°: -36.4kJ/mole logk: 1.35E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630394(US11802110, Compound 4.14)
ITC DataΔG°: -47.9kJ/mole −TΔS°: 3.98kJ/mole ΔH°: -51.7kJ/mole logk: 1.95E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630395(US11802110, Compound 4.15)
ITC DataΔG°: -45.5kJ/mole −TΔS°: 0kJ/mole ΔH°: -45.0kJ/mole logk: 9.46E+5
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630396(US11802110, Compound 4.16)
ITC DataΔG°: -43.3kJ/mole −TΔS°: -23.9kJ/mole ΔH°: -20.5kJ/mole logk: 4.78E+5
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630397(US11802110, Compound 4.17)
ITC DataΔG°: -47.7kJ/mole −TΔS°: -7.96kJ/mole ΔH°: -40.7kJ/mole logk: 1.81E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630398(US11802110, Compound 4.18)
ITC DataΔG°: -46.9kJ/mole −TΔS°: -15.9kJ/mole ΔH°: -29.4kJ/mole logk: 1.42E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630399(US11802110, Compound 4.19)
ITC DataΔG°: -48.4kJ/mole −TΔS°: -11.9kJ/mole ΔH°: -35.5kJ/mole logk: 2.24E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630400(US11802110, Compound 4.20)
ITC DataΔG°: -50.6kJ/mole −TΔS°: 0kJ/mole ΔH°: -48.7kJ/mole logk: 4.32E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630401(US11802110, Compound 4.21)
ITC DataΔG°: -46.7kJ/mole −TΔS°: -11.9kJ/mole ΔH°: -34.5kJ/mole logk: 1.35E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630402(US11802110, Compound 4.22)
ITC DataΔG°: -42.6kJ/mole −TΔS°: -23.9kJ/mole ΔH°: -17.9kJ/mole logk: 3.86E+5
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630403(US11802110, Compound 4.23)
ITC DataΔG°: -44.3kJ/mole −TΔS°: -15.9kJ/mole ΔH°: -29.6kJ/mole logk: 6.49E+5
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630404(US11802110, Compound 4.27)
ITC DataΔG°: -48.1kJ/mole −TΔS°: -11.9kJ/mole ΔH°: -36.5kJ/mole logk: 2.08E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630405(US11802110, Compound 4.29)
ITC DataΔG°: -45.9kJ/mole −TΔS°: 0kJ/mole ΔH°: -45.9kJ/mole logk: 1.05E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630406(US11802110, Compound 4.31)
ITC DataΔG°: -46.7kJ/mole −TΔS°: 7.96kJ/mole ΔH°: -54.3kJ/mole logk: 1.33E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630407(US11802110, Compound 4.32)
ITC DataΔG°: -47.6kJ/mole −TΔS°: -3.98kJ/mole ΔH°: -44.5kJ/mole logk: 1.76E+6
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630408(US11802110, Compound 4.34)
ITC DataΔG°: -37.4kJ/mole −TΔS°: 3.98kJ/mole ΔH°: -41.4kJ/mole logk: 8.07E+4
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630409(US11802110, Compound 4.35)
ITC DataΔG°: -44.5kJ/mole −TΔS°: -3.98kJ/mole ΔH°: -41.7kJ/mole logk: 6.91E+5
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
CellLeucine--tRNA ligase(Escherichia coli (strain K12))
Oxford Drug Design

US Patent
SyringePNGBDBM630388(US11802110, Compound S-4.1)
ITC DataΔG°: -28.8kJ/mole −TΔS°: -19.9kJ/mole ΔH°: -9.76kJ/mole logk: 6.00E+3
pH: 7.5 T: 125.01°C 
Syringe InfoPC cidPC sid
In DepthDetails US Patent
  • Reorder this table by ΔG°
  • Reorder this table by ΔH°
  • Reorder this table by ΔS°
  • Reorder this table by T
  • Change energy unit to:  kcal/mol